Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Stroke

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 205 articles:
HTML format



Single Articles


    July 2021
  1. SHOJI S, Kuno T, Fujisaki T, Takagi H, et al
    De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2021 Jul 9. pii: S0735-1097(21)05327.
    PubMed     Abstract available


    May 2021
  2. BAUERSACHS RM, Szarek M, Brodmann M, Gudz I, et al
    Total Ischemic Event Reduction with Rivaroxaban after Peripheral Arterial Revascularization in the VOYAGER PAD Trial.
    J Am Coll Cardiol. 2021 May 7. pii: S0735-1097(21)05016.
    PubMed     Abstract available


  3. HERZOG CA, Simegn MA, Xu Y, Costa SR, et al
    Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04965.
    PubMed     Abstract available


    April 2021
  4. GARCIA S, Dehghani P, Grines C, Davidson L, et al
    Initial Findings From the North American COVID-19 Myocardial Infarction Registry.
    J Am Coll Cardiol. 2021;77:1994-2003.
    PubMed     Abstract available


  5. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    PubMed    


  6. YAFASOVA A, Fosbol EL, Schou M, Baslund B, et al
    Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
    J Am Coll Cardiol. 2021;77:1717-1727.
    PubMed     Abstract available


    March 2021
  7. TSIMIKAS S, Moriarty PM, Stroes ES
    Emerging RNA Therapeutics to Lower Blood Levels of Lp(a): JACC Focus Seminar 2/4.
    J Am Coll Cardiol. 2021;77:1576-1589.
    PubMed     Abstract available


  8. BOS D, Arshi B, van den Bouwhuijsen QJA, Ikram MK, et al
    Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events.
    J Am Coll Cardiol. 2021;77:1426-1435.
    PubMed     Abstract available


    February 2021
  9. KEZERLE L, Tsadok MA, Akriv A, Senderey AB, et al
    Pre-Diabetes Increases Stroke Risk in Patients With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:875-884.
    PubMed     Abstract available


  10. KRAWISZ AK, Rosenfield K, White CJ, Jaff MR, et al
    Clinical Impact of Contralateral Carotid Occlusion in Patients Undergoing Carotid Artery Revascularization.
    J Am Coll Cardiol. 2021;77:835-844.
    PubMed     Abstract available


  11. BERTRAND PB, Overbey JR, Zeng X, Levine RA, et al
    Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
    J Am Coll Cardiol. 2021;77:713-724.
    PubMed     Abstract available


  12. HUSSAIN A, Sun W, Deswal A, de Lemos JA, et al
    Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
    J Am Coll Cardiol. 2021;77:559-571.
    PubMed     Abstract available


    December 2020
  13. MORTENSEN MB, Dzaye O, Steffensen FH, Botker HE, et al
    Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.
    J Am Coll Cardiol. 2020;76:2803-2813.
    PubMed     Abstract available


  14. BHAGIRATH VC, Chan N, Hirsh J, Ginsberg J, et al
    Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose.
    J Am Coll Cardiol. 2020;76:2906-2907.
    PubMed    


  15. SPOSATO LA, Hilz MJ, Aspberg S, Murthy SB, et al
    Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;76:2768-2785.
    PubMed     Abstract available


  16. BURNETT JR, Hooper AJ, Hegele RA
    Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk.
    J Am Coll Cardiol. 2020;76:2736-2739.
    PubMed    


  17. ROTH GA, Mensah GA, Johnson CO, Addolorato G, et al
    Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.
    J Am Coll Cardiol. 2020 Dec 3. pii: S0735-1097(20)37775.
    PubMed     Abstract available


  18. FAN J, Fang X, Liu C, Zhu G, et al
    Brain Injury After Transcatheter Replacement of Bicuspid Versus Tricuspid Aortic Valves.
    J Am Coll Cardiol. 2020;76:2579-2590.
    PubMed     Abstract available


    November 2020
  19. PARK DW, Yang Y
    Delay, Death, and Heterogeneity of Primary PCI During the COVID-19 Pandemic: An International Perspective.
    J Am Coll Cardiol. 2020;76:2331-2333.
    PubMed    


  20. KRAMER CM, Treiman GS
    Vulnerable Plaque in Carotid Arteries Without "Significant" Stenosis: Unmasking the Hidden Links to Stroke.
    J Am Coll Cardiol. 2020;76:2223-2225.
    PubMed    


  21. KOPCZAK A, Schindler A, Bayer-Karpinska A, Koch ML, et al
    Complicated Carotid Artery Plaques as a Cause of Cryptogenic Stroke.
    J Am Coll Cardiol. 2020;76:2212-2222.
    PubMed     Abstract available


  22. PIAZZA G
    Advanced Management of Intermediate- and High-Risk Pulmonary Embolism: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;76:2117-2127.
    PubMed     Abstract available


    October 2020
  23. CHAN YH, Chao TF, Lee HF, Yeh YH, et al
    Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes.
    J Am Coll Cardiol. 2020;76:1808-1810.
    PubMed    


    September 2020
  24. CAMM AJ, Cools F, Virdone S, Bassand JP, et al
    Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
    J Am Coll Cardiol. 2020;76:1425-1436.
    PubMed     Abstract available


  25. SEMERANO A, Roveri L, Martino G, Filippi M, et al
    Dampened Immune Response After Early Recurrence of Ischemic Stroke.
    J Am Coll Cardiol. 2020;76:1385-1387.
    PubMed    


    August 2020
  26. SZAREK M, Amarenco P, Callahan A, Goldstein LB, et al
    Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond.
    J Am Coll Cardiol. 2020;76:886-888.
    PubMed    


  27. SPENCE JD
    Intracerebral Hemorrhage in SPARCL: What Was the Relationship to LDL-C?
    J Am Coll Cardiol. 2020;76:885-886.
    PubMed    


  28. ASTRUP A, Magkos F, Bier DM, Brenna JT, et al
    Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;76:844-857.
    PubMed     Abstract available


  29. RIGATELLI G, Zuin M
    Atrial Aneurysm, Right-to-Left Shunt, and Risk of Stroke.
    J Am Coll Cardiol. 2020;76:761.
    PubMed    


    July 2020
  30. JAAKKOLA S, Nuotio I, Hartikainen JEK, Airaksinen KEJ, et al
    Early Cardioversion for Acute Atrial Fibrillation in Low Stroke Risk Patients Is Safe Without Anticoagulation.
    J Am Coll Cardiol. 2020;76:226-227.
    PubMed    


    June 2020
  31. SPYROPOULOS AC, Ageno W, Albers GW, Elliott CG, et al
    Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
    J Am Coll Cardiol. 2020;75:3140-3147.
    PubMed     Abstract available


  32. OSMANCIK P, Herman D, Neuzil P, Hala P, et al
    Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:3122-3135.
    PubMed     Abstract available


  33. POOLE JE, Bahnson TD, Monahan KH, Johnson G, et al
    Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    J Am Coll Cardiol. 2020;75:3105-3118.
    PubMed     Abstract available


    May 2020
  34. CHO L, Davis M, Elgendy I, Epps K, et al
    Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:2602-2618.
    PubMed     Abstract available


  35. THALER DE
    Risk Management: "High-Risk" PFOs Come Into Partial Focus.
    J Am Coll Cardiol. 2020;75:2321-2322.
    PubMed    


  36. TURC G, Lee JY, Brochet E, Kim JS, et al
    Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.
    J Am Coll Cardiol. 2020;75:2312-2320.
    PubMed     Abstract available


  37. ELGENDY IY, Gad MM, Mahmoud AN, Keeley EC, et al
    Reply: Factors Associated With Acute Stroke During Pregnancy and Puerperium.
    J Am Coll Cardiol. 2020;75:2280-2281.
    PubMed    


  38. ZHOU X, Tang G
    Factors Associated With Acute Stroke During Pregnancy and Puerperium.
    J Am Coll Cardiol. 2020;75:2279-2280.
    PubMed    


  39. SZAREK M, Amarenco P, Callahan A, DeMicco D, et al
    Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial.
    J Am Coll Cardiol. 2020;75:2110-2118.
    PubMed     Abstract available


    April 2020
  40. PATEL P, Yavagal D, Khandelwal P
    Hyperacute Management of Ischemic Strokes: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;75:1844-1856.
    PubMed     Abstract available


  41. OSPEL JM, Holodinsky JK, Goyal M
    Management of Acute Ischemic Stroke Due to Large-Vessel Occlusion: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;75:1832-1843.
    PubMed     Abstract available


  42. MAHMUD E, Dauerman HL, Welt FG, Messenger JC, et al
    Management of Acute Myocardial Infarction During the COVID-19 Pandemic.
    J Am Coll Cardiol. 2020 Apr 21. pii: S0735-1097(20)35026.
    PubMed     Abstract available


  43. MCALISTER FA, Youngson E
    Impact of the Generic Valsartan Recall in Alberta, Canada.
    J Am Coll Cardiol. 2020;75:1860-1862.
    PubMed    


  44. DIENER HC, Hankey GJ
    Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar.
    J Am Coll Cardiol. 2020;75:1804-1818.
    PubMed     Abstract available


  45. CHUNG MK, Refaat M, Shen WK, Kutyifa V, et al
    Atrial Fibrillation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1689-1713.
    PubMed     Abstract available


  46. GUO Y, Lane DA, Wang L, Zhang H, et al
    Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1523-1534.
    PubMed     Abstract available


  47. FREEMAN JV, Varosy P, Price MJ, Slotwiner D, et al
    The NCDR Left Atrial Appendage Occlusion Registry.
    J Am Coll Cardiol. 2020;75:1503-1518.
    PubMed     Abstract available


    March 2020
  48. DAUERMAN HL
    Darkness on the Edge of Thrombolysis.
    J Am Coll Cardiol. 2020;75:1422-1425.
    PubMed    


  49. MCCARTNEY PJ, Maznyczka AM, Eteiba H, McEntegart M, et al
    Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time.
    J Am Coll Cardiol. 2020;75:1406-1421.
    PubMed     Abstract available


  50. POKORNEY SD, Black-Maier E, Hellkamp AS, Friedman DJ, et al
    Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;75:1299-1308.
    PubMed     Abstract available


  51. CHENG EP, Yeo I, Kim LK, Lerman BB, et al
    Reply: Early Mortality Following Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1245-1247.
    PubMed    


  52. BOLLMANN A, Konig S, Basedow F, Hindricks G, et al
    Early Mortality After Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1243-1244.
    PubMed    


  53. ZEITOUNI M, Giczewska A, Lopes RD, Wojdyla DM, et al
    Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial.
    J Am Coll Cardiol. 2020;75:1145-1155.
    PubMed     Abstract available


    February 2020
  54. GUASCH-FERRE M, Liu G, Li Y, Sampson L, et al
    Olive Oil Consumption and Cardiovascular Risk in U.S. Adults.
    J Am Coll Cardiol. 2020 Feb 27. pii: S0735-1097(20)34332.
    PubMed     Abstract available


  55. SIONTIS KC, Checkole S, Yao X, Gersh BJ, et al
    Do Observational Studies Agree With Randomized Trials?: Evaluation of Oral Anticoagulants in Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:562-563.
    PubMed    


    January 2020
  56. NTAIOS G
    Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:333-340.
    PubMed     Abstract available


  57. KUNO T, Takagi H, Ando T, Sugiyama T, et al
    Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    J Am Coll Cardiol. 2020;75:273-285.
    PubMed     Abstract available


  58. ELGENDY IY, Gad MM, Mahmoud AN, Keeley EC, et al
    Acute Stroke During Pregnancy and Puerperium.
    J Am Coll Cardiol. 2020;75:180-190.
    PubMed     Abstract available


  59. SACCO RL, Sur NB
    Rising Incidence of Stroke in Pregnancy: A Call for Enhanced Screening and Prevention.
    J Am Coll Cardiol. 2020;75:191-193.
    PubMed    


  60. DI BIASE L, Mohanty S, Romero J, Della Rocca DG, et al
    Reply: LAA Electrical Isolation: A Tool to Achieve Superior Ablation Success Under Protection of Optimal Anticoagulation.
    J Am Coll Cardiol. 2020;75:130-131.
    PubMed    


  61. ADELINO R, Bazan V, Villuendas R, Bisbal F, et al
    Left Atrial Appendage Isolation and Preserved Function: Is it Really Isolated?
    J Am Coll Cardiol. 2020;75:129-130.
    PubMed    


  62. COHEN A
    Is Persistent Isolation of the LAA Necessary to Achieve Higher Success Rates in Atrial Fibrillation?
    J Am Coll Cardiol. 2020;75:128-129.
    PubMed    


  63. REDDY VY
    Reply: Common Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation: A Neurologist's and Neuroradiologist's Perspective.
    J Am Coll Cardiol. 2020;75:127-128.
    PubMed    


  64. PAPANAGIOTOU P, Tsivgoulis G
    Common Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation: A Neurologist's and Neuroradiologist's Perspective.
    J Am Coll Cardiol. 2020;75:126-127.
    PubMed    


    December 2019
  65. RUSSAK AJ, Johnson KW, Halperin JL, Percha B, et al
    Racial and Sex Differences in Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:3069-3070.
    PubMed    


  66. ALKHOULI M, Friedman PA
    Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:3050-3065.
    PubMed     Abstract available


    November 2019
  67. CHOI EK, Lee SR, Oh S, Lip GYH, et al
    Reply: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2330-2331.
    PubMed    


  68. GUO W, Tian X, Qiu L, Li L, et al
    Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2329-2330.
    PubMed    


    October 2019
  69. GAGE BF
    Warfarin-Induced Fractures in Atrial Fibrillation?
    J Am Coll Cardiol. 2019;74:2159-2161.
    PubMed    


  70. KUMAR S, Lim E, Covic A, Verhamme P, et al
    Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:2204-2215.
    PubMed     Abstract available


  71. MANGIERI A, Montalto C, Poletti E, Sticchi A, et al
    Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:2088-2101.
    PubMed     Abstract available


  72. COLLET JP, Zeitouni M, Procopi N, Hulot JS, et al
    Long-Term Evolution of Premature Coronary Artery Disease.
    J Am Coll Cardiol. 2019;74:1868-1878.
    PubMed     Abstract available


    September 2019
  73. GOROG DA, Lip GYH
    Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor?: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:1366-1375.
    PubMed     Abstract available


    August 2019
  74. DI BIASE L, Mohanty S, Trivedi C, Romero J, et al
    Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage.
    J Am Coll Cardiol. 2019;74:1019-1028.
    PubMed     Abstract available


    July 2019
  75. QAMAR A, Antman EM, Ruff CT, Nordio F, et al
    Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.
    J Am Coll Cardiol. 2019;74:179-189.
    PubMed     Abstract available


  76. BALLANTYNE CM
    Lipoprotein(a) and Risk for Stroke and Myocardial Infarction: Why Aren't We Screening?
    J Am Coll Cardiol. 2019;74:67-69.
    PubMed    


  77. CAPODANNO D, Huber K, Mehran R, Lip GYH, et al
    Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:83-99.
    PubMed     Abstract available


  78. KIM JY, Kim SH
    Reply: Off-Label Use of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362-3363.
    PubMed    


  79. HUANG B
    Atrial Fibrillation Accompanying Mitral Stenosis: Another Fortress Captured by Direct Oral Anticoagulants?
    J Am Coll Cardiol. 2019;73:3361-3362.
    PubMed    


  80. LEE SR, Lee HJ, Choi EK, Han KD, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;73:3295-3308.
    PubMed     Abstract available


    June 2019
  81. HENGSTENBERG C, Siller-Matula JM
    Shedding Light on Long-Term Effects of Early Antiplatelet Strategies After Fibrinolytic Treatment in STEMI.
    J Am Coll Cardiol. 2019;73:2829-2831.
    PubMed    


    May 2019
  82. REDDY VY, Neuzil P, de Potter T, van der Heyden J, et al
    A Percutaneous Permanent Carotid Filter for Stroke Prevention in Atrial Fibrillation: The CAPTURE Trial.
    J Am Coll Cardiol. 2019 May 8. pii: S0735-1097(19)35006.
    PubMed     Abstract available


    April 2019
  83. WHITE CJ
    Acute Stroke Intervention: The Role of Interventional Cardiologists.
    J Am Coll Cardiol. 2019;73:1491-1493.
    PubMed    


  84. HOLMES DR JR, Hopkins LN
    Interventional Cardiology and Acute Stroke Care Going Forward: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:1483-1490.
    PubMed     Abstract available


    March 2019
  85. KIM JY, Kim SH, Myong JP, Kim YR, et al
    Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:1123-1131.
    PubMed     Abstract available


  86. CONEN D, Rodondi N, Muller A, Beer JH, et al
    Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:989-999.
    PubMed     Abstract available


  87. BERWANGER O, Lopes RD, Moia DDF, Fonseca FA, et al
    Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial.
    J Am Coll Cardiol. 2019 Mar 12. pii: S0735-1097(19)33879.
    PubMed     Abstract available


  88. GONZALEZ NR
    Endovascular Thrombectomy Procedure Time and Other Predictors of Futility in Acute Ischemic Stroke Interventions.
    J Am Coll Cardiol. 2019;73:891-892.
    PubMed    


  89. ALAWIEH A, Vargas J, Fargen KM, Langley EF, et al
    Impact of Procedure Time on Outcomes of Thrombectomy for Stroke.
    J Am Coll Cardiol. 2019;73:879-890.
    PubMed     Abstract available


    February 2019
  90. AHN SH, Kim YH, Lee JS, Han JH, et al
    Troponin I Levels and Long-Term Outcomes in Acute Ischemic Stroke Patients.
    J Am Coll Cardiol. 2019;73:525-526.
    PubMed    


    January 2019
  91. TURAGAM MK, Lakkireddy D
    Reply: Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion.
    J Am Coll Cardiol. 2019;73:381.
    PubMed    


  92. PORTA-SANCHEZ A, Pizarro G, Salvador-Montanes O, Sanchez-Quintana D, et al
    Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion.
    J Am Coll Cardiol. 2019;73:380-381.
    PubMed    


  93. EICHELMANN F, Schulze MB, Wittenbecher C, Menzel J, et al
    Chemerin as a Biomarker Linking Inflammation and Cardiovascular Diseases.
    J Am Coll Cardiol. 2019;73:378-379.
    PubMed    


  94. WINTZER-WEHEKIND J, Alperi A, Houde C, Cote JM, et al
    Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
    J Am Coll Cardiol. 2019;73:278-287.
    PubMed     Abstract available


    December 2018
  95. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Left Atrial Appendage Closure in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:2806-2807.
    PubMed    


  96. THUESEN AL, Riber LP, Veien KT, Christiansen EH, et al
    Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2018;72:2732-2743.
    PubMed     Abstract available


    November 2018
  97. KIRCHHOF P, Bach M, Camm AJ
    Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2546-2547.
    PubMed    


  98. LI HF, Hong Y
    Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2545-2546.
    PubMed    


  99. WINDECKER S, Franzone A, Pilgrim T
    Deciphering the Unknowns of Stroke After Aortic Valve Interventions.
    J Am Coll Cardiol. 2018;72:2427-2430.
    PubMed    


  100. KAPADIA SR, Huded CP, Kodali SK, Svensson LG, et al
    Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    J Am Coll Cardiol. 2018;72:2415-2426.
    PubMed     Abstract available


  101. JUNG H, Sung JH, Yang PS, Jang E, et al
    Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2018;72:2409-2411.
    PubMed    


    October 2018
  102. DURKO AP, Reardon MJ, Kleiman NS, Popma JJ, et al
    Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients.
    J Am Coll Cardiol. 2018;72:2109-2119.
    PubMed     Abstract available


  103. CHEN ST, Melloni C
    Atrial Fibrillation in Cancer Patients: Recognizing Gaps in Care.
    J Am Coll Cardiol. 2018;72:1923-1925.
    PubMed    


  104. O'NEAL WT, Claxton JS, Sandesara PB, MacLehose RF, et al
    Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
    J Am Coll Cardiol. 2018;72:1913-1922.
    PubMed     Abstract available


  105. SINDET-PEDERSEN C, Lamberts M, Staerk L, Nissen Bonde A, et al
    Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
    J Am Coll Cardiol. 2018;72:1790-1800.
    PubMed     Abstract available


  106. SABATE M, Brugaletta S
    Thrombectomy and Stroke: Guilty or Innocent Bystander?
    J Am Coll Cardiol. 2018;72:1597-1599.
    PubMed    


  107. JOLLY SS, Cairns JA, Lavi S, Cantor WJ, et al
    Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial.
    J Am Coll Cardiol. 2018;72:1589-1596.
    PubMed     Abstract available


  108. BAUMGARTNER I, Norgren L, Fowkes FGR, Mulder H, et al
    Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial.
    J Am Coll Cardiol. 2018;72:1563-1572.
    PubMed     Abstract available


    September 2018
  109. CHIKWE J, Lee T, Itagaki S, Adams DH, et al
    Long-Term Outcomes After Off-Pump Versus On-Pump Coronary Artery Bypass Grafting by Experienced Surgeons.
    J Am Coll Cardiol. 2018;72:1478-1486.
    PubMed     Abstract available


  110. CORBALAN R, Nicolau JC, Lopez-Sendon J, Garcia-Castillo A, et al
    Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2018;72:1466-1475.
    PubMed     Abstract available


  111. BONDE AN, Staerk L, Lee CJ, Vinding NE, et al
    Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control.
    J Am Coll Cardiol. 2018;72:1357-1365.
    PubMed     Abstract available


  112. TURAGAM MK, Vuddanda V, Verberkmoes N, Ohtsuka T, et al
    Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.
    J Am Coll Cardiol. 2018;72:1346-1353.
    PubMed     Abstract available


  113. STUART JJ, Tanz LJ, Cook NR, Spiegelman D, et al
    Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction.
    J Am Coll Cardiol. 2018;72:1252-1263.
    PubMed     Abstract available


  114. KIM D, Yang PS, Kim TH, Jang E, et al
    Ideal Blood Pressure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1233-1245.
    PubMed     Abstract available


  115. BERKOWITZ SA, Sussman JB, Jonas DE, Basu S, et al
    Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus.
    J Am Coll Cardiol. 2018;72:1214-1223.
    PubMed     Abstract available


  116. QI Y, Han X, Zhao D, Wang W, et al
    Long-Term Cardiovascular Risk Associated With Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline.
    J Am Coll Cardiol. 2018;72:1201-1210.
    PubMed     Abstract available


  117. COLANTONIO LD, Booth JN 3rd, Bress AP, Whelton PK, et al
    2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.
    J Am Coll Cardiol. 2018;72:1187-1197.
    PubMed     Abstract available


  118. SILVESTRE OM, Nadruz W Jr, Querejeta Roca G, Claggett B, et al
    Declining Lung Function and Cardiovascular Risk: The ARIC Study.
    J Am Coll Cardiol. 2018;72:1109-1122.
    PubMed     Abstract available


    August 2018
  119. STEENSIG K, Olesen KKW, Thim T, Nielsen JC, et al
    Coronary artery disease is independent risk factor for stroke among patients with atrial fibrillation.
    J Am Coll Cardiol. 2018 Aug 23. pii: S0735-1097(18)36961.
    PubMed    


  120. LEE SR, Choi EK, Han KD, Jung JH, et al
    Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety.
    J Am Coll Cardiol. 2018;72:838-853.
    PubMed     Abstract available


    July 2018
  121. KRISHNASWAMY A, Kapadia SR
    Minimizing Stroke and Mortality Risks in Coronary Revascularization.
    J Am Coll Cardiol. 2018;72:399-401.
    PubMed    


  122. KEA B, Lin AL, Olshansky B, Malveau S, et al
    Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:471-472.
    PubMed    


  123. HEAD SJ, Milojevic M, Daemen J, Ahn JM, et al
    Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    J Am Coll Cardiol. 2018;72:386-398.
    PubMed     Abstract available


  124. LAW SWY, Lau WCY, Wong ICK, Lip GYH, et al
    Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:271-282.
    PubMed     Abstract available


  125. KENT AP, Brueckmann M, Fraessdorf M, Connolly SJ, et al
    Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:255-267.
    PubMed     Abstract available


  126. KIRCHHOF P, Radaideh G, Kim YH, Lanas F, et al
    Global Prospective Safety Analysis of Rivaroxaban.
    J Am Coll Cardiol. 2018;72:141-153.
    PubMed     Abstract available


  127. HEALEY JS
    Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal?
    J Am Coll Cardiol. 2018;72:154-155.
    PubMed    


    June 2018
  128. TURAGAM MK, Velagapudi P, Kar S, Holmes D, et al
    Cardiovascular Therapies Targeting Left Atrial Appendage.
    J Am Coll Cardiol. 2018 Jun 25. pii: S0735-1097(18)35139.
    PubMed     Abstract available


  129. ALKHOULI M, Noseworthy PA, Rihal CS, Holmes DR Jr, et al
    Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.
    J Am Coll Cardiol. 2018;71:2790-2801.
    PubMed     Abstract available


  130. GLOTZER TV
    The Cacophony of Silent Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:2612-2615.
    PubMed    


    May 2018
  131. DEVGUN JK, Gul S, Mohananey D, Jones BM, et al
    Cerebrovascular Events After Cardiovascular Procedures: Risk Factors, Recognition, and Prevention Strategies.
    J Am Coll Cardiol. 2018;71:1910-1920.
    PubMed     Abstract available


    March 2018
  132. KING JB, Marrouche N
    Reply: What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1054-1056.
    PubMed    


  133. REN JF, Callans DJ, Marchlinski FE
    What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1053-1054.
    PubMed    


  134. DAABOUL Y, Korjian S, Plotnikov AN, Burton P, et al
    Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome.
    J Am Coll Cardiol. 2018;71:1048-1049.
    PubMed    


  135. HICKS KA, Mahaffey KW, Mehran R, Nissen SE, et al
    2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
    J Am Coll Cardiol. 2018;71:1021-1034.
    PubMed     Abstract available


    February 2018
  136. NAGENDRAN J, Bozso SJ, Norris CM, McAlister FA, et al
    Coronary Artery Bypass Surgery Improves Outcomes in Patients With Diabetes and Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2018;71:819-827.
    PubMed     Abstract available


  137. FERREIRA JP, Girerd N, Gregson J, Latar I, et al
    Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:727-735.
    PubMed     Abstract available


  138. MAYR M, Gerszten R, Kiechl S
    Cardiovascular Risk Beyond Low-Density Lipoprotein Cholesterol.
    J Am Coll Cardiol. 2018;71:633-635.
    PubMed    


  139. HOLMES MV, Millwood IY, Kartsonaki C, Hill MR, et al
    Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke.
    J Am Coll Cardiol. 2018;71:620-632.
    PubMed     Abstract available


  140. BANSILAL S, Bonaca MP, Cornel JH, Storey RF, et al
    Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.
    J Am Coll Cardiol. 2018;71:489-496.
    PubMed     Abstract available


    January 2018
  141. GAGE BF
    Stroke Prediction Rules in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:133-134.
    PubMed    


  142. SHIN JI, Luo S, Alexander GC, Inker LA, et al
    Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:251-252.
    PubMed    


  143. CHAO TF, Lip GYH, Liu CJ, Lin YJ, et al
    Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:122-132.
    PubMed     Abstract available


    December 2017
  144. REDDY VY, Doshi SK, Kar S, Gibson DN, et al
    5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    J Am Coll Cardiol. 2017;70:2964-2975.
    PubMed     Abstract available


    November 2017
  145. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;70:2734-2735.
    PubMed    


  146. SHROFF GR
    NOAC Dosing in Atrial Fibrillation and Renal Dysfunction: What Measure Are You Using?
    J Am Coll Cardiol. 2017;70:2733-2734.
    PubMed    


  147. WEITZ JI, Fredenburgh JC, Eikelboom JW
    A Test in Context: D-Dimer.
    J Am Coll Cardiol. 2017;70:2411-2420.
    PubMed     Abstract available


    October 2017
  148. GOROG DA, Fayad ZA, Fuster V
    Arterial Thrombus Stability: Does It Matter and Can We Detect It?
    J Am Coll Cardiol. 2017;70:2036-2047.
    PubMed     Abstract available


    September 2017
  149. PAQUETTE M, Riou Franca L, Teutsch C, Diener HC, et al
    Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1573-1583.
    PubMed     Abstract available


    August 2017
  150. MAGNUSON EA, Li H, Wang K, Vilain K, et al
    Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.
    J Am Coll Cardiol. 2017;70:527-538.
    PubMed     Abstract available


    July 2017
  151. EPPINGA RN, Hartman MHT, Verweij N, van der Harst JJ, et al
    Refining Thromboembolic Risk in the General Population.
    J Am Coll Cardiol. 2017;70:403-404.
    PubMed    


  152. WHANG W
    Opportunities to Improve Outcomes in Atrial Fibrillation: Provider Specialty and Beyond.
    J Am Coll Cardiol. 2017;70:87-88.
    PubMed    


    June 2017
  153. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    PubMed     Abstract available


  154. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;69:2779-2790.
    PubMed     Abstract available


    May 2017
  155. MARZEC LN, Wang J, Shah ND, Chan PS, et al
    Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2475-2484.
    PubMed     Abstract available


  156. PETERSON ED, Pokorney SD
    New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2485-2487.
    PubMed    


  157. SARDAR P, Chatterjee S, Aronow HD, Kundu A, et al
    Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention: A Meta-Analysis of Clinical Trials.
    J Am Coll Cardiol. 2017;69:2266-2275.
    PubMed     Abstract available


    April 2017
  158. JOSHI FR, Manavaki R, Fryer TD, Figg NL, et al
    Vascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography Is Influenced by Hypoxia.
    J Am Coll Cardiol. 2017;69:1873-1874.
    PubMed    


    March 2017
  159. KONSTANTINIDES SV, Vicaut E, Danays T, Becattini C, et al
    Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.
    J Am Coll Cardiol. 2017;69:1536-1544.
    PubMed     Abstract available


  160. DE CATERINA R, Renda G, Carnicelli AP, Nordio F, et al
    Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2017;69:1372-1382.
    PubMed     Abstract available


  161. RENDA G, Ricci F, Giugliano RP, De Caterina R, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
    J Am Coll Cardiol. 2017;69:1363-1371.
    PubMed     Abstract available


    February 2017
  162. ZHAO DF, Edelman JJ, Seco M, Bannon PG, et al
    Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis.
    J Am Coll Cardiol. 2017;69:924-936.
    PubMed     Abstract available


  163. HUISMAN MV, Rothman KJ, Paquette M, Teutsch C, et al
    The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    J Am Coll Cardiol. 2017;69:777-785.
    PubMed     Abstract available


    January 2017
  164. CAHILL TJ, Baddour LM, Habib G, Hoen B, et al
    Challenges in Infective Endocarditis.
    J Am Coll Cardiol. 2017;69:325-344.
    PubMed     Abstract available


  165. BYUN YS, Yang X, Bao W, DeMicco D, et al
    Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.
    J Am Coll Cardiol. 2017;69:147-158.
    PubMed     Abstract available


  166. VAN DIEPEN S, Fuster V, Verma S, Hamza TH, et al
    Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    J Am Coll Cardiol. 2017;69:119-127.
    PubMed     Abstract available


    December 2016
  167. GOMEZ-OUTES A, Lagunar-Ruiz J, Terleira-Fernandez AI, Calvo-Rojas G, et al
    Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:2508-2521.
    PubMed     Abstract available


  168. HSU JC, Maddox TM, Marcus GM
    Reply: Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.
    J Am Coll Cardiol. 2016;68:2493.
    PubMed    


  169. BROWN JD, Shewale AR, Dherange P, Talbert JC, et al
    Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.
    J Am Coll Cardiol. 2016;68:2492.
    PubMed    


    November 2016
  170. GUREWICH V
    Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved.
    J Am Coll Cardiol. 2016;68:2099-2106.
    PubMed     Abstract available


  171. ELGENDY I, Mahmoud A, Bavry A
    TCT-194 Is routine aspiration thrombectomy associated with a higher risk of stroke? A meta-analysis of randomized trials.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  172. LARSON D, Garberich R, Lips D, Burke MN, et al
    TCT-173 Safety of Very Early (< 3hrs) Routine Percutaneous Coronary Intervention after Fibrinolysis in ST-segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  173. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-153 Acute Stroke During Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  174. GUTTMANN O, Perera D, Jain A, Mathur A, et al
    TCT-146 Routine Aspiration thrombectomy is associated with increased stroke rates during primary percutaneous coronary intervention for myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed    


  175. VERGARA R, Valenti R, Migliorini A, Parodi G, et al
    TCT-145 Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    J Am Coll Cardiol. 2016;68.
    PubMed    


    October 2016
  176. LLOYD-JONES DM, Huffman MD, Karmali KN, Sanghavi DM, et al
    Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool.
    J Am Coll Cardiol. 2016 Oct 28. pii: S0735-1097(16)36692.
    PubMed     Abstract available


  177. REDDY VY, Gibson DN, Kar S, O'Neill W, et al
    Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36641.
    PubMed     Abstract available


    September 2016
  178. LAU YC, Proietti M, Guiducci E, Blann AD, et al
    Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2016;68:1452-64.
    PubMed     Abstract available


  179. CHAN YH, Kuo CT, Yeh YH, Chang SH, et al
    Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1389-401.
    PubMed     Abstract available


  180. GOSMANOVA EO, Mikkelsen MK, Molnar MZ, Lu JL, et al
    Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.
    J Am Coll Cardiol. 2016;68:1375-86.
    PubMed     Abstract available


  181. ALEXOPOULOS D, Xanthopoulou I, Moulias A, Lekakis J, et al
    Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?
    J Am Coll Cardiol. 2016;68:1223-32.
    PubMed     Abstract available


  182. STEFFEL J, Giugliano RP, Braunwald E, Murphy SA, et al
    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
    J Am Coll Cardiol. 2016;68:1169-78.
    PubMed     Abstract available


  183. HYLEK EM, Ko D
    Atrial Fibrillation and Fall Risk: What Are the Treatment Implications?
    J Am Coll Cardiol. 2016;68:1179-80.
    PubMed    


  184. TAMAYO SG, Simeone JC, Nordstrom BL, Patel MR, et al
    Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1144-6.
    PubMed    


    August 2016
  185. BANSILAL S, Castellano JM, Garrido E, Wei HG, et al
    Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    J Am Coll Cardiol. 2016;68:789-801.
    PubMed     Abstract available


  186. AUFFRET V, Regueiro A, Del Trigo M, Abdul-Jawad Altisent O, et al
    Predictors of Early Cerebrovascular Events in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68:673-84.
    PubMed     Abstract available


  187. KABRA R, Girotra S, Vaughan Sarrazin M
    Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    J Am Coll Cardiol. 2016;68:461-70.
    PubMed     Abstract available


  188. GRANGER CB, Thomas KL
    Stroke Prediction in Atrial Fibrillation: Is it Black and White?
    J Am Coll Cardiol. 2016;68:471-2.
    PubMed    


    July 2016
  189. RAMOS R, Comas-Cufi M, Alves-Cabratosa L, Garcia-Gil M, et al
    Reply: Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.
    J Am Coll Cardiol. 2016;68:238.
    PubMed    


  190. KESER A, Ozbek K, Katlandur H, Ulucan S, et al
    Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.
    J Am Coll Cardiol. 2016;68:237-8.
    PubMed    


  191. DEL-CARPIO MUNOZ F, Yao X, Abraham NS, Bellolio MF, et al
    Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:129-31.
    PubMed    


    June 2016
  192. HSU JC, Maddox TM, Kennedy K, Katz DF, et al
    Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
    J Am Coll Cardiol. 2016;67:2913-23.
    PubMed     Abstract available


  193. NOSEWORTHY PA, Yao X, Shah ND, Gersh BJ, et al
    Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:3020-1.
    PubMed    


  194. KO MJ, Jo AJ, Park CM, Kim HJ, et al
    Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    J Am Coll Cardiol. 2016;67:2821-31.
    PubMed     Abstract available


    May 2016
  195. MODY P, Joshi PH, Khera A, Ayers CR, et al
    Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.
    J Am Coll Cardiol. 2016;67:2480-7.
    PubMed     Abstract available


  196. PIAZZA G, Karipineni N, Goldberg HS, Jenkins KL, et al
    Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2444-6.
    PubMed    


  197. VAN DEN HAM HA, Klungel OH, Singer DE, Leufkens HG, et al
    Reply: Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2317-8.
    PubMed    


  198. POTPARA TS, Olesen JB
    Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2316-7.
    PubMed    


  199. VRANCKX P, White HD, Huang Z, Mahaffey KW, et al
    Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
    J Am Coll Cardiol. 2016;67:2135-44.
    PubMed     Abstract available


  200. RANA JS, Tabada GH, Solomon MD, Lo JC, et al
    Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    J Am Coll Cardiol. 2016;67:2118-30.
    PubMed     Abstract available


  201. SAFDER TB, Badgett RG
    Predicting Stroke in Patients With Atrial Fibrillation: An Incomplete Picture Without Considering Quality of Anticoagulation.
    J Am Coll Cardiol. 2016;67:2192-3.
    PubMed    


    April 2016
  202. KARIO K, Saito I, Kushiro T, Teramukai S, et al
    Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study.
    J Am Coll Cardiol. 2016;67:1519-27.
    PubMed     Abstract available


  203. HERTTUA K, Martikainen P, Batty GD, Kivimaki M, et al
    Poor Adherence to Statin and Antihypertensive Therapies as Risk Factors for Fatal Stroke.
    J Am Coll Cardiol. 2016;67:1507-15.
    PubMed     Abstract available


    March 2016
  204. DEEB GM, Reardon MJ, Chetcuti S, Patel HJ, et al
    Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016 Mar 22. pii: S0735-1097(16)01690.
    PubMed     Abstract available


    August 2015
  205. HESS CN, Peterson ED, Peng SA, de Lemos JA, et al
    Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:616-27.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: